Yi-Cheng Zhu Selected Research

Yi-Cheng Zhu Research Topics

Disease

4	Stroke (Strokes) 02/2024 - 01/2013
4	Inflammation (Inflammations) 01/2022 - 01/2013
3	Atrophy 01/2023 - 11/2010
3	Thyroid Nodule (Nodule, Thyroid) 08/2022 - 10/2021
2	Dementia (Dementias) 02/2024 - 07/2022
2	Neoplasms (Cancer) 11/2023 - 01/2018
2	Ischemic Stroke 04/2022 - 01/2013
2	Cerebral Small Vessel Diseases 01/2022 - 12/2021
2	Atherosclerosis 01/2022 - 12/2021
1	Breast Neoplasms (Breast Cancer) 11/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2022
1	Necrosis 01/2022
1	CADASIL 12/2021
1	Depressive Disorder (Melancholia) 12/2020
1	Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 10/2020
1	Fever (Fevers) 01/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Mesenteric Lymphadenitis 07/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Uterine Prolapse (Vaginal Prolapse) 11/2018
1	Rectocele 11/2018
1	Cystocele 11/2018
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2018
1	Diabetes Mellitus 01/2018
1	Drug Resistant Epilepsy 11/2015
1	Autoimmune Diseases of the Nervous System 11/2015
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 11/2015
1	Epilepsy (Aura) 11/2015
1	Brain Infarction 07/2013
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2013

Drug/Important Bio-Agent (IBA)

3	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 08/2022 - 10/2021
2	Epidermal Growth Factor (EGF)IBA 02/2024 - 12/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
2	C-Reactive ProteinIBA 01/2022 - 01/2013
2	AntibodiesIBA 01/2020 - 11/2015
2	Apolipoproteins E (ApoE)IBA 07/2013 - 11/2010
1	Long Noncoding RNAIBA 11/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2023
1	CollagenIBA 01/2023
1	Complement C3 (C3 Complement)IBA 01/2023
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2023
1	MXeneIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 07/2022
1	ChitinasesIBA 01/2022
1	HomocysteineIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	P-SelectinIBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	E-SelectinIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	CD40 Ligand (CD40L)IBA 01/2022
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2022
1	OsteopontinIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	LipidsIBA 12/2021
1	ApolipoproteinsIBA 01/2021
1	PowdersIBA 12/2020
1	Serine (L-Serine)FDA Link 10/2020
1	Peptide Hydrolases (Proteases)FDA Link 10/2020
1	Serine Proteases (Serine Protease)IBA 10/2020
1	Amino Acids FDA Link 10/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	AntigensIBA 01/2020
1	SteroidsIBA 01/2020
1	N 30IBA 07/2019
1	CholesterolIBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	LDL CholesterolIBA 01/2018
1	HDL CholesterolIBA 01/2018
1	GABA Receptors (GABA Receptor)IBA 11/2015
1	gamma-Aminobutyric Acid (GABA)IBA 11/2015
1	Aminobutyrates (Aminobutyric Acid)IBA 11/2015
1	3-n-butylphthalide (butylphthalide)IBA 01/2013

Therapy/Procedure

2	Therapeutics 04/2022 - 01/2018
2	Immunotherapy 01/2018 - 11/2015
1	Activities of Daily Living (ADL) 01/2023
1	Surgical Instruments (Clip) 11/2018